ExodusPoint Capital Management, LP

Position in DNLI — Denali Therapeutics Inc.

CIK 1736225 NEW YORK, NY

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,656,503

-$8,237,404 QoQ

Shares Held

336,567

-67.1% QoQ

Ownership

0.211%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#52

of 286 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $275,349,927 across 101 Biotechnology names. DNLI ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc. This page	336,567	$8,656,503

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,656,503	336,567	-67.1%	Shares	Sole	2026-08-14
2025-12-31	$16,893,907	1,023,253	+5787.2%	Shares	Sole	2026-02-17
2023-09-30	$358,570	17,381	-30.2%	Shares	Sole	2023-11-13
2023-03-31	$573,857	24,907	+6.3%	Shares	Other	2023-05-11
2022-09-30	$719,189	23,434	-63.5%	Shares	Other	2022-11-10
2022-06-30	$1,889,023	64,187	+206.3%	Shares	Sole	2022-08-22
2021-06-30	$1,644,023	20,959	+266.2%	Shares	Sole	2021-08-16
2020-09-30	$205,055	5,723	-63.4%	Shares	Sole	2020-11-16
2020-06-30	$378,102	15,637	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.